1. Home
  2. MDBH vs MIRA Comparison

MDBH vs MIRA Comparison

Compare MDBH & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.43

Market Cap

35.0M

Sector

N/A

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$1.58

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
MIRA
Founded
1997
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0M
33.7M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
MDBH
MIRA
Price
$3.43
$1.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.6K
259.9K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$1,250,398.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$0.73
52 Week High
$7.98
$2.45

Technical Indicators

Market Signals
Indicator
MDBH
MIRA
Relative Strength Index (RSI) 50.50 57.36
Support Level $3.17 $1.52
Resistance Level $3.62 $1.69
Average True Range (ATR) 0.17 0.08
MACD 0.02 0.01
Stochastic Oscillator 57.78 60.71

Price Performance

Historical Comparison
MDBH
MIRA

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: